These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22027220)

  • 21. Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor.
    Hofmann B; Rödl CB; Kahnt AS; Maier TJ; Michel AA; Hoffmann M; Rau O; Awwad K; Pellowska M; Wurglics M; Wacker M; Zivković A; Fleming I; Schubert-Zsilavecz M; Stark H; Schneider G; Steinhilber D
    Br J Pharmacol; 2012 Apr; 165(7):2304-13. PubMed ID: 21955369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of novel 2-amino-5-hydroxyindole derivatives that inhibit human 5-lipoxygenase.
    Landwehr J; George S; Karg EM; Poeckel D; Steinhilber D; Troschuetz R; Werz O
    J Med Chem; 2006 Jul; 49(14):4327-32. PubMed ID: 16821792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoxygenase inhibitors as potential cancer chemopreventives.
    Steele VE; Holmes CA; Hawk ET; Kopelovich L; Lubet RA; Crowell JA; Sigman CC; Kelloff GJ
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):467-83. PubMed ID: 10350444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
    J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity.
    Werz O; Szellas D; Henseler M; Steinhilber D
    Mol Pharmacol; 1998 Aug; 54(2):445-51. PubMed ID: 9687587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of novel aminothiazole-comprising 5-LO inhibitors.
    M Kretschmer SB; Woltersdorf S; Rödl CB; Vogt D; Häfner AK; Steinhilber D; Stark H; Hofmann B
    Future Med Chem; 2016; 8(2):149-64. PubMed ID: 26824797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases.
    Werz O; Klemm J; Samuelsson B; Rådmark O
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5261-6. PubMed ID: 10779545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816.
    Hutchinson JH; Riendeau D; Brideau C; Chan C; Delorme D; Denis D; Falgueyret JP; Fortin R; Guay J; Hamel P
    J Med Chem; 1993 Sep; 36(19):2771-87. PubMed ID: 8410991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of 5-lipoxygenase by U73122 is due to covalent binding to cysteine 416.
    Hörnig M; Markoutsa S; Häfner AK; George S; Wisniewska JM; Rödl CB; Hofmann B; Maier T; Karas M; Werz O; Steinhilber D
    Biochim Biophys Acta; 2012 Feb; 1821(2):279-86. PubMed ID: 22137889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
    Strub A; Ulrich WR; Hesslinger C; Eltze M; Fuchss T; Strassner J; Strand S; Lehner MD; Boer R
    Mol Pharmacol; 2006 Jan; 69(1):328-37. PubMed ID: 16223957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and biological evaluation of novel 1,4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase.
    Filosa R; Peduto A; Aparoy P; Schaible AM; Luderer S; Krauth V; Petronzi C; Massa A; de Rosa M; Reddanna P; Werz O
    Eur J Med Chem; 2013 Sep; 67():269-79. PubMed ID: 23871907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib inhibits 5-lipoxygenase.
    Maier TJ; Tausch L; Hoernig M; Coste O; Schmidt R; Angioni C; Metzner J; Groesch S; Pergola C; Steinhilber D; Werz O; Geisslinger G
    Biochem Pharmacol; 2008 Oct; 76(7):862-72. PubMed ID: 18692027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-Lipoxygenase inhibitors: a review of recent developments and patents.
    Pergola C; Werz O
    Expert Opin Ther Pat; 2010 Mar; 20(3):355-75. PubMed ID: 20180620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoxygenase Inhibitors as Cancer Chemopreventives: Discovery, Recent Developments and Future Perspectives.
    Mahboubi-Rabbani M; Zarghi A
    Curr Med Chem; 2021; 28(6):1143-1175. PubMed ID: 31820690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes.
    Filosa R; Peduto A; Schaible AM; Krauth V; Weinigel C; Barz D; Petronzi C; Bruno F; Roviezzo F; Spaziano G; D'Agostino B; De Rosa M; Werz O
    Eur J Med Chem; 2015 Apr; 94():132-9. PubMed ID: 25765759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase.
    Tiso M; Strub A; Hesslinger C; Kenney CT; Boer R; Stuehr DJ
    Mol Pharmacol; 2008 Apr; 73(4):1244-53. PubMed ID: 18178668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of lipoxygenation in human natural killer cell activation.
    Bray RA; Brahmi Z
    J Immunol; 1986 Mar; 136(5):1783-90. PubMed ID: 3081633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
    Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T
    Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
    Odell LR; Nilsson MT; Gising J; Lagerlund O; Muthas D; Nordqvist A; Karlén A; Larhed M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4790-3. PubMed ID: 19560924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.